CA Stock MarketDetailed Quotes

Imagin Medical Inc (IME)

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
162.45KMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Imagin Medical Inc (IME) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-59.19%356.29K
-54.56%362.42K
-14.19%669.21K
-8.38%3.55M
-18.25%1.1M
-10.37%872.96K
-11.12%797.64K
18.41%779.89K
-11.52%3.87M
95.34%1.34M
Selling and administrative expenses
-35.59%309.96K
-30.64%315.53K
-4.77%323.9K
-31.04%1.46M
-72.09%178.78K
0.79%481.2K
-17.22%454.95K
-23.12%340.14K
-4.93%2.11M
18.39%640.56K
-General and administrative expense
-35.59%309.96K
-30.64%315.53K
-4.77%323.9K
-31.04%1.46M
-72.09%178.78K
0.79%481.2K
-17.22%454.95K
-23.12%340.14K
-4.93%2.11M
18.39%640.56K
Research and development costs
--0
-99.83%553
-30.81%298.99K
18.01%2.05M
28.69%895.57K
-21.48%384.11K
-1.58%335.04K
106.85%432.1K
-18.44%1.73M
427.07%695.9K
Depreciation amortization depletion
505.62%46.33K
505.62%46.33K
505.62%46.33K
60.38%47.13K
229.14%24.18K
4.12%7.65K
4.14%7.65K
4.12%7.65K
-8.67%29.39K
-50.54%7.35K
-Depreciation and amortization
505.62%46.33K
505.62%46.33K
505.62%46.33K
60.38%47.13K
229.14%24.18K
4.12%7.65K
4.14%7.65K
4.12%7.65K
-8.67%29.39K
-50.54%7.35K
Operating profit
59.19%-356.29K
54.56%-362.42K
14.19%-669.21K
8.38%-3.55M
18.25%-1.1M
10.37%-872.96K
11.12%-797.64K
-18.41%-779.89K
11.52%-3.87M
-95.34%-1.34M
Net non-operating interest income (expenses)
47.61%-1.16K
-39.28%-510.59K
-34.93%-2.28K
-13.06%-7.83K
-28.63%-2.19K
-50.41%-2.21K
-17,790.73%-366.58K
0.88%-1.69K
-225.34%-6.93K
-756.76%-1.7K
Non-operating interest income
----
--0
----
----
----
----
--0
----
----
----
Non-operating interest expense
-47.61%1.16K
-17.18%1.44K
34.93%2.28K
13.06%7.83K
28.63%2.19K
50.41%2.21K
-15.08%1.74K
-0.88%1.69K
-12.48%6.93K
6.98%1.7K
Total other finance cost
----
39.55%509.14K
----
----
----
----
--364.84K
----
----
----
Other net income (expenses)
-53.65%2.56M
-101.69%-270
227.10%687.48K
114.02%1.06M
47.68%-3.57M
921.32%5.52M
101.13%15.94K
-651.39%-540.91K
-178,131.97%-7.59M
-488,998.57%-6.82M
Gain on sale of security
-109.47%-914
-101.69%-270
127.19%1.4K
161.95%23.3K
-86.01%2.95K
145.09%9.65K
168.97%15.94K
63.65%-5.15K
-783.03%-37.62K
1,610.40%21.06K
Special income (charges)
-53.55%2.56M
----
228.06%686.08K
113.78%1.04M
47.80%-3.57M
880.71%5.51M
----
-577.29%-535.76K
---7.56M
---6.84M
-Less:Other special charges
53.55%-2.56M
----
-228.06%-686.08K
-113.78%-1.04M
-47.80%3.57M
-880.71%-5.51M
----
577.29%535.76K
--7.56M
--6.84M
Income before tax
-52.61%2.2M
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.67%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
Income tax
Earnings from equity interest net of tax
Net income
-52.61%2.2M
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.67%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
Net income continuous operations
-52.61%2.2M
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.67%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
Noncontrolling interests
Net income attributable to the company
-52.61%2.2M
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.67%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-52.61%2.2M
23.95%-873.27K
101.21%15.99K
78.28%-2.49M
42.82%-4.67M
1,168.67%4.65M
50.35%-1.15M
-135.21%-1.32M
-162.14%-11.47M
-1,084.74%-8.16M
Diluted earnings per share
-57.45%0.2
33.33%-0.08
101.43%0.002
80.31%-0.25
47.78%-0.47
1,040.00%0.47
53.85%-0.12
-133.33%-0.14
-139.62%-1.27
-1,185.71%-0.9
Basic earnings per share
-57.45%0.2
33.33%-0.08
101.43%0.002
80.31%-0.25
47.78%-0.47
1,040.00%0.47
53.85%-0.12
-133.33%-0.14
-139.62%-1.27
-1,185.71%-0.9
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -59.19%356.29K-54.56%362.42K-14.19%669.21K-8.38%3.55M-18.25%1.1M-10.37%872.96K-11.12%797.64K18.41%779.89K-11.52%3.87M95.34%1.34M
Selling and administrative expenses -35.59%309.96K-30.64%315.53K-4.77%323.9K-31.04%1.46M-72.09%178.78K0.79%481.2K-17.22%454.95K-23.12%340.14K-4.93%2.11M18.39%640.56K
-General and administrative expense -35.59%309.96K-30.64%315.53K-4.77%323.9K-31.04%1.46M-72.09%178.78K0.79%481.2K-17.22%454.95K-23.12%340.14K-4.93%2.11M18.39%640.56K
Research and development costs --0-99.83%553-30.81%298.99K18.01%2.05M28.69%895.57K-21.48%384.11K-1.58%335.04K106.85%432.1K-18.44%1.73M427.07%695.9K
Depreciation amortization depletion 505.62%46.33K505.62%46.33K505.62%46.33K60.38%47.13K229.14%24.18K4.12%7.65K4.14%7.65K4.12%7.65K-8.67%29.39K-50.54%7.35K
-Depreciation and amortization 505.62%46.33K505.62%46.33K505.62%46.33K60.38%47.13K229.14%24.18K4.12%7.65K4.14%7.65K4.12%7.65K-8.67%29.39K-50.54%7.35K
Operating profit 59.19%-356.29K54.56%-362.42K14.19%-669.21K8.38%-3.55M18.25%-1.1M10.37%-872.96K11.12%-797.64K-18.41%-779.89K11.52%-3.87M-95.34%-1.34M
Net non-operating interest income (expenses) 47.61%-1.16K-39.28%-510.59K-34.93%-2.28K-13.06%-7.83K-28.63%-2.19K-50.41%-2.21K-17,790.73%-366.58K0.88%-1.69K-225.34%-6.93K-756.76%-1.7K
Non-operating interest income ------0------------------0------------
Non-operating interest expense -47.61%1.16K-17.18%1.44K34.93%2.28K13.06%7.83K28.63%2.19K50.41%2.21K-15.08%1.74K-0.88%1.69K-12.48%6.93K6.98%1.7K
Total other finance cost ----39.55%509.14K------------------364.84K------------
Other net income (expenses) -53.65%2.56M-101.69%-270227.10%687.48K114.02%1.06M47.68%-3.57M921.32%5.52M101.13%15.94K-651.39%-540.91K-178,131.97%-7.59M-488,998.57%-6.82M
Gain on sale of security -109.47%-914-101.69%-270127.19%1.4K161.95%23.3K-86.01%2.95K145.09%9.65K168.97%15.94K63.65%-5.15K-783.03%-37.62K1,610.40%21.06K
Special income (charges) -53.55%2.56M----228.06%686.08K113.78%1.04M47.80%-3.57M880.71%5.51M-----577.29%-535.76K---7.56M---6.84M
-Less:Other special charges 53.55%-2.56M-----228.06%-686.08K-113.78%-1.04M-47.80%3.57M-880.71%-5.51M----577.29%535.76K--7.56M--6.84M
Income before tax -52.61%2.2M23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.67%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M
Income tax
Earnings from equity interest net of tax
Net income -52.61%2.2M23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.67%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M
Net income continuous operations -52.61%2.2M23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.67%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M
Noncontrolling interests
Net income attributable to the company -52.61%2.2M23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.67%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -52.61%2.2M23.95%-873.27K101.21%15.99K78.28%-2.49M42.82%-4.67M1,168.67%4.65M50.35%-1.15M-135.21%-1.32M-162.14%-11.47M-1,084.74%-8.16M
Diluted earnings per share -57.45%0.233.33%-0.08101.43%0.00280.31%-0.2547.78%-0.471,040.00%0.4753.85%-0.12-133.33%-0.14-139.62%-1.27-1,185.71%-0.9
Basic earnings per share -57.45%0.233.33%-0.08101.43%0.00280.31%-0.2547.78%-0.471,040.00%0.4753.85%-0.12-133.33%-0.14-139.62%-1.27-1,185.71%-0.9
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -